Upcoming Allied Market Research
Isocarboxazid Market

Isocarboxazid Market

by Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), : Global Opportunity Analysis and Industry Forecast, 2022-2032

Report Code: A50484
Pages: NA
Apr 2023 | 85 Views
Author(s) : Onkar S
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

Isocarboxazid is a nonselective and irreversible antidepressant. It is a type of drug that inhibits the action of monoamine oxidase enzyme and belongs to the hydrazine class. It is primarily used for the treatment of anxiety and depression and is specifically used when all other treatments fail to show any clinical response. It has been approved in the U.S. for the treatment of depression and licensed for the treatment of depression in the UK, when a person is unresponsive to selective serotonin reuptake inhibitors.
The isocarboxazid market is anticipated to grow significantly during the forecast period owing to various driving factors. The emergence of COVID-19 witnessed an increase in major depressive disorder and anxiety disorder cases globally. This pandemic specifically affected the more vulnerable population like people living in poverty, older people, people with disabilities, youth, and indigenous peoples. Millions of workers; waged and self-employed, regularly faced high levels of working poverty, loss of economy, and educational crisis. Most of the population felt lonely, frustrated, and vulnerable, physically, emotionally, and financially which ultimately led to depressive episodes. During this period, the market share of antidepressant drugs expanded gradually. Among these, isocarboxazid market showed good sales during the pandemic period. Some people, even after being treated with antidepressants do not show any clinical response. At this time, isocarboxazid drugs can be used for the treatment of major depressive disorder. Hence, the unresponsiveness of other antidepressants and treatment-resistant depression may also act as a driver for this market. Furthermore, there are various biologic innovations and novel technologies for the treatment of depression. Since there is an increase in mental disorders, which is also life-threatening, various organizations have taken interest in funding research for newer therapies with minimal side effects. These may help to expand this market in the forecast period. 
Although the isocarboxazid market is witnessing an upsurge, some restraints may hinder the growth of the market. Isocarboxazid usage is accompanied by several adverse effects. At the beginning of treatment, some patients—especially those who are younger than 24—may have suicidal thoughts. Other common side effects include fainting, mood changes, muscle stiffness, changes in sexual ability or interest, shivering, swollen ankles or legs, unusual weight gain, and vision changes like double or blurred vision. A serious interaction between this, and other medications, such as antibiotics and some other antidepressants, may occur. Therefore, it is critical to take caution when administering other drugs. Moreover, severe withdrawal symptoms such as agitation, confusion, hallucinations, headache, weakness, and diarrhea may emerge if this medicine is discontinued abruptly. These factors could limit this market's growth. In addition, these medications could be expensive hence making them accessible to a small group. All these factors are predicted to impede the market's expansion for isocarboxazid.
According to the 2021 anxiety and depression Association of America report, anxiety was found to be one of the most common disorders in the U.S.. This can create various new opportunities for key players to expand the isocarboxazid market. Isocarboxazid is mainly used when all other treatments fail to show any effect, this may also help the expansion of this market. The increasing cases of depression, especially post-pandemic has also created new opportunities. New product launches as well as new research for novel treatments with fewer side effects may drive the demand for isocarboxazid market
New product launches to flourish in the market
Segment Overview:    
In hospital pharmacy, patients receive their isocarboxazid prescriptions straight from the hospital. A hospital pharmacy provides medical services like compounding and dispensing of the drug. These services are offered to both inpatients and outpatients; inpatients are those who are admitted to the same hospital, whilst outpatients are those who visit the hospital for a checkup or treatment. Online pharmacies have rapidly become popular in recent years. Most people prefer to order their medications online to avoid having to travel to a physical pharmacy. However, there can be some drawbacks to this kind of channel of distribution. There have been multiple cases of unregistered or unlicensed pharmacies dispensing adulterated, spurious, or mislabeled drugs. In addition, online pharmacies do not offer the required consultation for such medications that are often offered at retail or hospital pharmacies. Antidepressants may also be lethal if the correct dosage is not given. These factors could all limit how widely isocarboxazid is distributed online. Retail pharmacies are those that dispense medical supplies and prescription medications to the general public. While dispensing medication, it must be checked if the patient is carrying a proper prescription given by a registered medical practitioner. 
Competitive analysis and profiles of the major players in the isocarboxazid market, such as Amneal Pharmaceuticals, Inc., Chemspec chemicals private limited, GlaxoSmithKline plc, Jigs Chemical, Medilink, Parke-Davis, Roberts Laboratories, Schering, Validus Pharmaceuticals LLC, Zeneca are provided in this report. 

Isocarboxazid Market Report Highlights

Aspects Details
By Distribution Channel
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players Validus Pharmaceuticals LLC, Medilink, Roberts Laboratories, Amneal Pharmaceuticals, Inc., chemspec chemicals private limited, Jigs Chemical, GlaxoSmithKline plc, Schering, Zeneca, Parke-Davis

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Isocarboxazid Market

Start reading.
This Report and over 19,981+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,600
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers